Latest News

NWPX Infrastructure (NWPX) is attracting fresh attention after reporting the first commercial use of its patent pending Permalok Radial Bending Joint in Tampa Bay Water’s South Hillsborough Pipeline microtunneling project. See our latest analysis for NWPX Infrastructure. At a latest share price of $67.29, NWPX Infrastructure has paired the Permalok RBJ milestone with steady short term momentum, including a 7 day share price return of 5.12%. Longer term total shareholder returns of 41.99% over...

In recent months, Perseus Mining has reported robust financial results, highlighted by a 19% return on equity and 33% net income growth over five years, supported by significant profit reinvestment into the business. This combination of high profitability and a reinvestment-focused approach has reinforced confidence in Perseus Mining’s ability to sustain earnings momentum, even as analysts anticipate slower growth ahead. Against this backdrop of strong return on equity, we’ll now consider...

Dn Agrar Group (BVB:DN) has had a great run on the share market with its stock up by a significant 13% over the last...

West Red Lake Gold Mines (TSXV:WRLG) has put its 100% owned Madsen Gold Mine into commercial production as of January 1, 2026. This marks a key step that turns years of project work into ongoing operations. See our latest analysis for West Red Lake Gold Mines. The commercial production news lands after a strong run in the shares, with a 1-day share price return of 4.93% and a 1-year total shareholder return of 98.31%, suggesting momentum has been building as operational milestones at Madsen...

What ABIVAX Société Anonyme’s recent performance means for investors ABIVAX Société Anonyme (ENXTPA:ABVX) has drawn attention after a period where its share price shows a mix of shorter term softness and stronger past 3 months and 1 year returns, inviting a closer look at fundamentals. See our latest analysis for ABIVAX Société Anonyme. Over the past year, ABIVAX Société Anonyme’s share price has been volatile, with a recent 3 month share price return of 25.6% contrasting with a year to date...

GQG Partners Inc. has confirmed that, effective January 1, 2026, Charles Falck succeeded retiring CFO Melodie Zakaluk, bringing more than 20 years of investment management experience and recent Deputy CFO and COO responsibilities to the role. Falck’s progression from overseeing GQG’s global operational infrastructure to leading its finance function, after senior roles at Vontobel Asset Management and Goldman Sachs, may influence how the firm manages growth, risk, and capital...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...

Royalty growth outlook and capital deployment signal focus areas for investors Ligand Pharmaceuticals (LGND) recently highlighted an expected 40% royalty revenue increase in 2026 and a 23% compound annual growth rate projection through 2030, alongside more than US$1b in deployable capital for new investments. See our latest analysis for Ligand Pharmaceuticals. Those royalty growth projections and the large capital pool are arriving after a sharp move in the stock, with a 1 year total...

Hilbert Group AB (publ)'s ( STO:HILB B ) price-to-sales (or "P/S") ratio of 4.2x may not look like an appealing...

Qantec Automation has announced a new alliance with ABB to deliver open, sustainable smart building and IoT automation solutions across Australia, combining ABB’s building technologies with Qantec’s local market expertise. This collaboration highlights how ABB is using local distribution partnerships to deepen its presence in the smart building segment and support more efficient, lower‑emission infrastructure. We’ll now explore how ABB’s expanded Australian smart building footprint with...

With a price-to-earnings (or "P/E") ratio of 31.8x Speedvalue Ltd ( TLV:SPDV ) may be sending very bearish signals at...

Zevra Therapeutics (ZVRA) is in focus as its leadership prepares to present at the J.P. Morgan 44th Annual Healthcare Conference on January 15, 2026, where it will outline rare disease programs and broader growth plans. See our latest analysis for Zevra Therapeutics. The upcoming J.P. Morgan conference appearance follows a 1-day share price return of 6.44% and a 7-day share price return of 7.34%. Over the past 90 days, the share price declined by 24.28%, contrasting with a 1-year total...

Waystar Holding (WAY) just introduced agentic intelligence to its cloud-native AltitudeAI platform, with the aim of automating more of the healthcare revenue cycle and reducing manual work related to authorizations, denials, and claims corrections. See our latest analysis for Waystar Holding. Despite the agentic intelligence launch and recent conference spotlight, Waystar Holding’s share price has eased to US$30.58, with a 90 day share price return of 16.74% and a 1 year total shareholder...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Sino Biopharmaceutical’s board previously reported enrollment of the first patient in a global first Phase III trial of TDI01, a highly selective ROCK2 inhibitor for idiopathic pulmonary fibrosis, following encouraging Phase II efficacy and safety data. The same molecule has also entered Breakthrough Therapy Designation review in China for chronic graft-versus-host disease, underlining its potential relevance across multiple serious immune-related conditions. We’ll now examine how advancing...

Carnival Corporation recently entered a 10‑year offtake agreement for liquified natural gas with Stabilis Solutions to supply its Port of Galveston operations starting in late 2027, contingent on financing and construction of a new LNG facility. This long-term LNG commitment, paired with a series of positive analyst views, highlights how fuel sourcing and sustainability are becoming central to Carnival’s business model. We’ll now explore how Carnival’s long-term LNG supply deal may influence...

With its stock down 15% over the past three months, it is easy to disregard Singular People (BME:SNG). We, however...

Marathon Petroleum (MPC) is back on many investors’ screens after its recent share price moves, with the stock showing a modest gain over the past week but declines over the month and past 3 months. See our latest analysis for Marathon Petroleum. Zooming out, Marathon Petroleum’s 6.49% year to date share price return and 20.30% one year total shareholder return suggest momentum has cooled recently after a stronger run and may indicate shifting expectations around future cash flows and...

Executive shifts and trade pressures put PDD Holdings (PDD) in focus Recent leadership changes at PDD Holdings, including new senior appointments alongside existing co-CEOs, come as the company operates through tighter U.S. trade rules, tariffs, and the removal of duty-free treatment for some China-origin shipments. See our latest analysis for PDD Holdings. The share price has been under pressure recently, with a 1-day share price return showing a 5.40% decline and a 7-day share price return...

If you are wondering whether Allegiant Travel's current share price still reflects its underlying value, you are not alone. This article will walk through what the market may be pricing in. The stock has had a mixed run, with a 7.7% decline over the last week, a roughly flat 0.2% return over the past month, and a 14.8% decline over the past year. The 3 year return sits at 10.3% and the 5 year return at a 51.9% decline. Recent attention on Allegiant Travel has focused on how its business...

While Hafnia Limited ( OB:HAFNI ) shareholders have had a good week with the stock up 11%, they shouldn't let their...

In recent days, Datadog has been at the center of mixed analyst reactions, with several firms reaffirming positive ratings while others downgraded the stock or removed it from preferred lists, all against a backdrop of sector rotation away from high-growth technology names. This divergence highlights how the same fundamentals, such as Datadog’s role in cloud observability and AI-related workloads, are being interpreted very differently, revealing a split view on competitive risks and...

With a price-to-earnings (or "P/E") ratio of 15.8x Gomero Group AB (Publ) ( FRA:EO8 ) may be sending bullish signals at...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...